Hypoxic hepatitis: underlying conditions and risk factors for mortality in critically ill patients
Hypoxic hepatitis (HH) is a frequent cause of acute hepatocellular damage at the intensive care unit. Although mortality is reported to be high, risk factors for mortality in this population are unknown.
One-hundred and seventeen consecutive patients with HH were studied prospectively at three medical intensive care units of a university hospital.
The main causes of hypoxic hepatitis were low cardiac output and septic shock, and most patients (74%) had more than one underlying factor. Peak aspartate transaminase (P = 0.02), lactate dehydrogenase (P = 0.03), INR (P < 0.001) and lactate (P < 0.01) were higher in non-survivors. Prolonged duration of HH caused higher overall mortality rate (P = 0.03). INR > 2 (P = 0.02), septic shock (P = 0.01) and SOFA score >10 (P = 0.04) were risk factors of mortality in the regression model.
Hypoxic hepatitis is the consequence of multiorgan injury. Outcome is influenced by the severity of liver impairment and the etiology and severity of the basic disease.
KeywordsIschemic hepatitis Shock liver Risk factors Hypoglycemia
Intensive care unit
Serum aspartate transaminase level
Serum alanine transaminase level
Lactate dehydrogenase level
International normalized ratio
Simplified acute physiology score
Sequential organ failure assessment
- 12.Kumar A, Roberts D, Wood KE, Light B, Parillo JE, Sharma S, Suppes S, Feinstein D, Zanotti S, Taiberg L, Gurka D, Kumar A, Cheang M (2006) Duration of hypotension prior to initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 34:1589–1596PubMedCrossRefGoogle Scholar
- 18.American College of Chest Physicians (Society of Critical Care Medicine Consensus Conference) (1992) Definition of sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20:864–874Google Scholar
- 20.Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N, Moerer O, Gruendling M, Oppert M, Grond S, Olthoff D, Jaschinski U, John S, Rossaint R, Welte T, Schaefer M, Kern P, Kuhnt E, Kiehntopf M, Hartog C, Natanson C, Loeffler M, Reinhart K, German Competence Network Sepsis (SepNet) (2008) Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 358:125–139PubMedCrossRefGoogle Scholar
- 24.Peralta C, Perales J, Bartrons R, Mitchell C, Gilgenkrantz H, Xaus C, Prats N, Fernandez N, Gelpi E, Panes J, Rosello-Catafau J (2002) The combination of ischemic preconditioning and liver Bcl-2 over expression is a suitable strategy to prevent liver and lung damage after hepatic ischemia-reperfusion. Am J Pathol 160:2111–2122PubMedGoogle Scholar
- 27.Stravitz RT, Kramer A, Davern T, Shaikh O, Caldwell SH, Mehta RL, Blei AT, Fontana RJ, McGuire BM, Rossaro L, Smith AD, Lee WM, Acute Liver Failure Study Group (2007) Intensive care of patients with acute liver failure: Recommendations of the U.S. Acute Liver Failure Study Group. Crit Care Med 35:2498–2508PubMedCrossRefGoogle Scholar
- 34.Kneidinger N, Fuhrmann V, Kitzberger R, Warszawska J, Holzinger U, Lindner G, Schenk P, Locker G, Heinz G, Madl C (2007) Intensive Care Med 33(2):0188Google Scholar